| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Acute Necrotizing | 10 | 2020 | 159 | 5.310 |
Why?
|
| Debridement | 8 | 2020 | 507 | 3.250 |
Why?
|
| Altitude Sickness | 8 | 2011 | 82 | 2.340 |
Why?
|
| Drainage | 6 | 2020 | 1089 | 2.180 |
Why?
|
| Altitude | 7 | 2011 | 122 | 1.900 |
Why?
|
| Cholecystectomy, Laparoscopic | 6 | 2020 | 255 | 1.900 |
Why?
|
| Cholecystitis, Acute | 4 | 2018 | 68 | 1.590 |
Why?
|
| Pulmonary Edema | 5 | 2011 | 425 | 1.510 |
Why?
|
| Pancreatitis | 5 | 2020 | 1041 | 1.200 |
Why?
|
| Gallstones | 3 | 2020 | 264 | 1.080 |
Why?
|
| Malnutrition | 5 | 2020 | 565 | 0.980 |
Why?
|
| Endoscopy | 4 | 2020 | 1656 | 0.930 |
Why?
|
| Intraoperative Complications | 9 | 2020 | 1239 | 0.880 |
Why?
|
| Mountaineering | 4 | 2010 | 43 | 0.880 |
Why?
|
| Nutrition Therapy | 2 | 2019 | 91 | 0.870 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2017 | 271 | 0.820 |
Why?
|
| Gallbladder | 3 | 2020 | 313 | 0.770 |
Why?
|
| Length of Stay | 17 | 2021 | 6042 | 0.740 |
Why?
|
| Hemorrhage | 6 | 2021 | 3028 | 0.730 |
Why?
|
| Clostridium difficile | 3 | 2017 | 412 | 0.720 |
Why?
|
| Intracranial Hypertension | 2 | 2011 | 154 | 0.710 |
Why?
|
| Intensive Care Units | 13 | 2020 | 3090 | 0.710 |
Why?
|
| Pancreas | 5 | 2020 | 1665 | 0.700 |
Why?
|
| Abdominal Abscess | 2 | 2015 | 145 | 0.690 |
Why?
|
| Cholecystostomy | 1 | 2017 | 50 | 0.690 |
Why?
|
| Cholecystectomy | 3 | 2017 | 384 | 0.670 |
Why?
|
| Enteral Nutrition | 8 | 2018 | 697 | 0.660 |
Why?
|
| Cholecystitis | 4 | 2020 | 194 | 0.640 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 461 | 0.630 |
Why?
|
| Intracranial Pressure | 2 | 2008 | 302 | 0.620 |
Why?
|
| Appendicitis | 3 | 2019 | 598 | 0.620 |
Why?
|
| Surgical Procedures, Operative | 8 | 2020 | 1918 | 0.610 |
Why?
|
| Cholelithiasis | 1 | 2017 | 425 | 0.600 |
Why?
|
| Critical Illness | 13 | 2021 | 2227 | 0.600 |
Why?
|
| Pancreatic Fistula | 1 | 2016 | 151 | 0.590 |
Why?
|
| Intestinal Fistula | 3 | 2021 | 153 | 0.560 |
Why?
|
| Optic Nerve | 2 | 2008 | 549 | 0.560 |
Why?
|
| Myelin Sheath | 2 | 2008 | 582 | 0.560 |
Why?
|
| Bile Duct Diseases | 1 | 2014 | 102 | 0.560 |
Why?
|
| Hospital Mortality | 11 | 2021 | 4845 | 0.540 |
Why?
|
| Glasgow Outcome Scale | 1 | 2013 | 92 | 0.530 |
Why?
|
| Ultrasonography | 5 | 2015 | 5774 | 0.520 |
Why?
|
| Postoperative Complications | 11 | 2020 | 14748 | 0.510 |
Why?
|
| Surgical Wound Infection | 3 | 2018 | 1399 | 0.510 |
Why?
|
| Wounds and Injuries | 7 | 2020 | 2406 | 0.500 |
Why?
|
| Radiography, Abdominal | 2 | 2020 | 615 | 0.490 |
Why?
|
| Trauma Centers | 8 | 2021 | 791 | 0.480 |
Why?
|
| Meckel Diverticulum | 1 | 2011 | 36 | 0.480 |
Why?
|
| Bezoars | 1 | 2011 | 26 | 0.470 |
Why?
|
| Teichoic Acids | 1 | 2012 | 72 | 0.470 |
Why?
|
| Abdomen | 4 | 2019 | 1098 | 0.450 |
Why?
|
| Middle Aged | 72 | 2021 | 210747 | 0.440 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2012 | 128 | 0.430 |
Why?
|
| Male | 92 | 2021 | 343917 | 0.430 |
Why?
|
| Critical Care | 8 | 2021 | 2284 | 0.430 |
Why?
|
| Cutaneous Fistula | 2 | 2021 | 84 | 0.420 |
Why?
|
| Polyurethanes | 3 | 2015 | 105 | 0.420 |
Why?
|
| Inflammation | 6 | 2018 | 9163 | 0.410 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2020 | 562 | 0.410 |
Why?
|
| Restraint, Physical | 1 | 2010 | 182 | 0.400 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 765 | 0.390 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1628 | 0.390 |
Why?
|
| Nutritional Status | 6 | 2020 | 1491 | 0.380 |
Why?
|
| Emergencies | 5 | 2020 | 1131 | 0.380 |
Why?
|
| Retroperitoneal Space | 2 | 2019 | 172 | 0.380 |
Why?
|
| Bupivacaine | 1 | 2012 | 424 | 0.380 |
Why?
|
| Female | 85 | 2021 | 365199 | 0.370 |
Why?
|
| Humans | 104 | 2021 | 660731 | 0.370 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 407 | 0.370 |
Why?
|
| Aged | 50 | 2021 | 156937 | 0.360 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 1012 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2020 | 20102 | 0.350 |
Why?
|
| Emergency Service, Hospital | 6 | 2020 | 6807 | 0.350 |
Why?
|
| Adult | 54 | 2021 | 206295 | 0.340 |
Why?
|
| Abdominal Injuries | 3 | 2015 | 341 | 0.340 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3200 | 0.340 |
Why?
|
| Retrospective Studies | 33 | 2021 | 63232 | 0.330 |
Why?
|
| Nepal | 4 | 2008 | 245 | 0.330 |
Why?
|
| Blood Proteins | 1 | 2012 | 1080 | 0.330 |
Why?
|
| Hypophosphatemia | 2 | 2017 | 81 | 0.320 |
Why?
|
| Pain, Postoperative | 2 | 2018 | 1406 | 0.320 |
Why?
|
| Patient Transfer | 1 | 2013 | 712 | 0.320 |
Why?
|
| General Surgery | 4 | 2018 | 1650 | 0.310 |
Why?
|
| Nerve Block | 1 | 2012 | 641 | 0.300 |
Why?
|
| Exsanguination | 2 | 2015 | 29 | 0.300 |
Why?
|
| Hospitalization | 9 | 2020 | 8701 | 0.300 |
Why?
|
| Neck Injuries | 2 | 2018 | 147 | 0.300 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 980 | 0.290 |
Why?
|
| Injury Severity Score | 8 | 2021 | 999 | 0.290 |
Why?
|
| Heart Rate | 5 | 2015 | 4166 | 0.290 |
Why?
|
| Intestine, Small | 1 | 2011 | 1321 | 0.280 |
Why?
|
| Laparotomy | 2 | 2018 | 462 | 0.280 |
Why?
|
| Emergency Treatment | 2 | 2018 | 510 | 0.280 |
Why?
|
| Thoracic Injuries | 3 | 2021 | 241 | 0.270 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2007 | 498 | 0.270 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 358 | 0.270 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2262 | 0.270 |
Why?
|
| Wounds, Gunshot | 2 | 2021 | 475 | 0.260 |
Why?
|
| Hemostatic Techniques | 2 | 2014 | 117 | 0.260 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 484 | 0.260 |
Why?
|
| Thromboembolism | 2 | 2021 | 969 | 0.250 |
Why?
|
| Patient Admission | 2 | 2020 | 1392 | 0.240 |
Why?
|
| Triage | 3 | 2021 | 905 | 0.240 |
Why?
|
| Brain Injuries | 1 | 2013 | 1796 | 0.240 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 1006 | 0.240 |
Why?
|
| Treatment Outcome | 21 | 2021 | 59149 | 0.240 |
Why?
|
| Risk Assessment | 12 | 2021 | 22923 | 0.230 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 15955 | 0.230 |
Why?
|
| Indiana | 1 | 2020 | 82 | 0.230 |
Why?
|
| Prospective Studies | 19 | 2021 | 46949 | 0.220 |
Why?
|
| Portal System | 1 | 2020 | 57 | 0.220 |
Why?
|
| Alkaline Phosphatase | 5 | 2014 | 901 | 0.220 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 865 | 0.220 |
Why?
|
| Panniculitis | 1 | 2020 | 48 | 0.220 |
Why?
|
| Hospital Costs | 1 | 2007 | 1006 | 0.210 |
Why?
|
| Aged, 80 and over | 18 | 2021 | 57680 | 0.210 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2020 | 72 | 0.210 |
Why?
|
| Rib Fractures | 1 | 2020 | 102 | 0.210 |
Why?
|
| Laparoscopy | 1 | 2011 | 2029 | 0.210 |
Why?
|
| Risk Factors | 21 | 2021 | 66887 | 0.200 |
Why?
|
| Sepsis | 1 | 2012 | 2216 | 0.200 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 102 | 0.190 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2018 | 27 | 0.190 |
Why?
|
| Crowding | 1 | 2020 | 159 | 0.190 |
Why?
|
| Choledocholithiasis | 1 | 2018 | 40 | 0.190 |
Why?
|
| Nutrition Assessment | 2 | 2019 | 721 | 0.190 |
Why?
|
| Ileostomy | 1 | 2019 | 120 | 0.190 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 127 | 0.190 |
Why?
|
| Cholangiography | 1 | 2018 | 195 | 0.190 |
Why?
|
| Dietary Proteins | 4 | 2018 | 958 | 0.190 |
Why?
|
| Video-Assisted Surgery | 1 | 2018 | 51 | 0.190 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2018 | 45 | 0.180 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2018 | 192 | 0.180 |
Why?
|
| Acetazolamide | 2 | 2008 | 104 | 0.180 |
Why?
|
| Duodenoscopy | 1 | 2017 | 48 | 0.180 |
Why?
|
| Psoas Muscles | 1 | 2018 | 58 | 0.180 |
Why?
|
| Protein Deficiency | 1 | 2017 | 69 | 0.180 |
Why?
|
| Training Support | 1 | 2018 | 126 | 0.180 |
Why?
|
| Hospitals, Community | 1 | 2020 | 314 | 0.180 |
Why?
|
| Diverticulitis, Colonic | 1 | 2019 | 124 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 5 | 2002 | 1970 | 0.180 |
Why?
|
| Wounds, Penetrating | 1 | 2019 | 291 | 0.180 |
Why?
|
| Time Factors | 10 | 2020 | 41842 | 0.170 |
Why?
|
| Blood Transfusion | 2 | 2021 | 1227 | 0.170 |
Why?
|
| Refeeding Syndrome | 1 | 2016 | 12 | 0.170 |
Why?
|
| Catheters | 1 | 2019 | 261 | 0.170 |
Why?
|
| Acute Disease | 4 | 2019 | 7143 | 0.170 |
Why?
|
| Bile | 1 | 2018 | 317 | 0.170 |
Why?
|
| United States | 19 | 2020 | 63218 | 0.170 |
Why?
|
| Prealbumin | 1 | 2018 | 172 | 0.170 |
Why?
|
| After-Hours Care | 1 | 2017 | 103 | 0.160 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 134 | 0.160 |
Why?
|
| Digestive System Fistula | 1 | 2015 | 10 | 0.160 |
Why?
|
| Osteoblasts | 3 | 2001 | 1195 | 0.160 |
Why?
|
| Plasma | 1 | 2019 | 542 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 2016 | 155 | 0.160 |
Why?
|
| Dura Mater | 4 | 2002 | 279 | 0.160 |
Why?
|
| Burns | 1 | 2007 | 1891 | 0.160 |
Why?
|
| Appendectomy | 2 | 2018 | 385 | 0.160 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 15093 | 0.160 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1719 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2011 | 3159 | 0.160 |
Why?
|
| Arthritis | 1 | 2020 | 632 | 0.150 |
Why?
|
| Survival Rate | 6 | 2021 | 13249 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 2 | 2021 | 1136 | 0.150 |
Why?
|
| Quality Improvement | 5 | 2019 | 3473 | 0.150 |
Why?
|
| Delayed Diagnosis | 2 | 2015 | 389 | 0.150 |
Why?
|
| Gelatin | 1 | 2016 | 208 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 2538 | 0.150 |
Why?
|
| Wounds, Stab | 1 | 2015 | 76 | 0.150 |
Why?
|
| Pneumothorax | 2 | 2020 | 358 | 0.150 |
Why?
|
| Serum Albumin | 1 | 2018 | 702 | 0.150 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1218 | 0.150 |
Why?
|
| Viscoelastic Substances | 1 | 2014 | 20 | 0.140 |
Why?
|
| Glasgow Coma Scale | 4 | 2020 | 488 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2018 | 731 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1700 | 0.140 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 727 | 0.140 |
Why?
|
| Fees and Charges | 1 | 2015 | 194 | 0.140 |
Why?
|
| Truth Disclosure | 1 | 2018 | 443 | 0.130 |
Why?
|
| Databases, Factual | 9 | 2020 | 7515 | 0.130 |
Why?
|
| Arteriovenous Malformations | 1 | 2016 | 379 | 0.130 |
Why?
|
| Logistic Models | 8 | 2016 | 13647 | 0.130 |
Why?
|
| Radar | 1 | 2012 | 8 | 0.130 |
Why?
|
| Energy Intake | 3 | 2018 | 2077 | 0.130 |
Why?
|
| Reflex, Pupillary | 1 | 2013 | 55 | 0.130 |
Why?
|
| Hemostatics | 1 | 2015 | 189 | 0.130 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2013 | 63 | 0.130 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 63 | 0.130 |
Why?
|
| Cholangitis | 1 | 2014 | 109 | 0.130 |
Why?
|
| Mycetoma | 1 | 2012 | 11 | 0.130 |
Why?
|
| Benchmarking | 2 | 2017 | 846 | 0.130 |
Why?
|
| Spinal Injuries | 1 | 2015 | 264 | 0.130 |
Why?
|
| Calcifediol | 1 | 2014 | 180 | 0.130 |
Why?
|
| Gangrene | 2 | 2015 | 80 | 0.120 |
Why?
|
| Diverticulitis | 1 | 2014 | 125 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 1950 | 0.120 |
Why?
|
| Parenteral Nutrition | 1 | 2017 | 628 | 0.120 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1684 | 0.120 |
Why?
|
| Massachusetts | 3 | 2020 | 8717 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2016 | 864 | 0.120 |
Why?
|
| Peritonitis | 1 | 2014 | 385 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2019 | 2390 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2018 | 651 | 0.120 |
Why?
|
| Warfarin | 1 | 2020 | 1398 | 0.120 |
Why?
|
| Violence | 1 | 2018 | 869 | 0.110 |
Why?
|
| Lung Diseases, Fungal | 1 | 2012 | 129 | 0.110 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 1247 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3235 | 0.110 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 13550 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3350 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2018 | 762 | 0.110 |
Why?
|
| Incidence | 9 | 2020 | 19739 | 0.110 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 509 | 0.110 |
Why?
|
| Cranial Sutures | 2 | 2001 | 86 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2015 | 593 | 0.110 |
Why?
|
| Blast Injuries | 1 | 2013 | 251 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2017 | 1557 | 0.110 |
Why?
|
| Duodenum | 1 | 2014 | 522 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2019 | 1049 | 0.110 |
Why?
|
| Age Factors | 5 | 2021 | 19040 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 918 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 471 | 0.100 |
Why?
|
| Ethanol | 1 | 2016 | 1229 | 0.100 |
Why?
|
| Thoracotomy | 1 | 2012 | 367 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2020 | 1049 | 0.100 |
Why?
|
| Patient Rights | 1 | 2010 | 129 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 1023 | 0.100 |
Why?
|
| Entropy | 3 | 2015 | 208 | 0.100 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 487 | 0.100 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2014 | 531 | 0.100 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2279 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1406 | 0.100 |
Why?
|
| Young Adult | 10 | 2021 | 54078 | 0.100 |
Why?
|
| Shock | 2 | 2021 | 318 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 38875 | 0.090 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2008 | 97 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2713 | 0.090 |
Why?
|
| Mortality | 1 | 2020 | 2739 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 5190 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1603 | 0.090 |
Why?
|
| Clostridium Infections | 1 | 2014 | 432 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2020 | 4010 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2018 | 15038 | 0.090 |
Why?
|
| Comorbidity | 5 | 2021 | 10445 | 0.090 |
Why?
|
| Hospitals | 2 | 2017 | 2740 | 0.090 |
Why?
|
| Internship and Residency | 2 | 2018 | 5141 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 1107 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 1247 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2004 | 0.090 |
Why?
|
| Patient Discharge | 2 | 2020 | 2581 | 0.090 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 12724 | 0.090 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 576 | 0.090 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2007 | 91 | 0.090 |
Why?
|
| Operating Rooms | 3 | 2019 | 766 | 0.090 |
Why?
|
| Burn Units | 1 | 2007 | 145 | 0.080 |
Why?
|
| Bed Rest | 1 | 2007 | 78 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1051 | 0.080 |
Why?
|
| Nifedipine | 1 | 2007 | 220 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1938 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 1479 | 0.080 |
Why?
|
| Skin | 1 | 2020 | 4362 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2020 | 37121 | 0.080 |
Why?
|
| Adolescent | 8 | 2020 | 82796 | 0.080 |
Why?
|
| Albuterol | 1 | 2007 | 204 | 0.080 |
Why?
|
| Skull | 2 | 2001 | 782 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 504 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 1202 | 0.080 |
Why?
|
| Prognosis | 5 | 2015 | 28027 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2759 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4335 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7485 | 0.070 |
Why?
|
| Recurrence | 1 | 2017 | 8072 | 0.070 |
Why?
|
| Iliac Artery | 1 | 2007 | 401 | 0.070 |
Why?
|
| Collagen | 4 | 2001 | 2727 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5112 | 0.070 |
Why?
|
| Sulfones | 1 | 2007 | 448 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1275 | 0.070 |
Why?
|
| Child | 5 | 2015 | 68786 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2340 | 0.070 |
Why?
|
| Osteocalcin | 2 | 2001 | 281 | 0.070 |
Why?
|
| Phosphates | 2 | 2017 | 751 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2011 | 4281 | 0.070 |
Why?
|
| Purines | 1 | 2007 | 549 | 0.070 |
Why?
|
| Stents | 1 | 2016 | 3216 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2016 | 8408 | 0.070 |
Why?
|
| Necrosis | 2 | 2018 | 1646 | 0.070 |
Why?
|
| Abdominal Pain | 2 | 2020 | 1006 | 0.060 |
Why?
|
| Sialoglycoproteins | 2 | 2002 | 393 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 4999 | 0.060 |
Why?
|
| Osteopontin | 2 | 2002 | 335 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 2797 | 0.060 |
Why?
|
| Reference Values | 2 | 2010 | 5150 | 0.060 |
Why?
|
| Curriculum | 1 | 2015 | 3011 | 0.060 |
Why?
|
| Travel | 1 | 2008 | 731 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3136 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2001 | 12483 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 1170 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 1337 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2001 | 1787 | 0.060 |
Why?
|
| Radiology | 1 | 2015 | 1827 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2002 | 649 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2014 | 2820 | 0.060 |
Why?
|
| Propensity Score | 2 | 2020 | 1684 | 0.060 |
Why?
|
| African Americans | 2 | 2007 | 4975 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2007 | 932 | 0.060 |
Why?
|
| Amputation | 1 | 2007 | 766 | 0.060 |
Why?
|
| Health Surveys | 2 | 2014 | 4084 | 0.060 |
Why?
|
| Boston | 3 | 2021 | 9418 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 3809 | 0.060 |
Why?
|
| Leg | 1 | 2007 | 1220 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1860 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2020 | 3031 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 1438 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 3049 | 0.050 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 49 | 0.050 |
Why?
|
| Neuromuscular Blockade | 1 | 2021 | 136 | 0.050 |
Why?
|
| Prone Position | 1 | 2021 | 181 | 0.050 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3864 | 0.050 |
Why?
|
| Pressure Ulcer | 1 | 2021 | 162 | 0.050 |
Why?
|
| Reoperation | 2 | 2020 | 4123 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2535 | 0.050 |
Why?
|
| Tokyo | 1 | 2018 | 22 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 639 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2021 | 717 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2020 | 561 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2001 | 1177 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2021 | 307 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 705 | 0.050 |
Why?
|
| Fascia | 1 | 2018 | 132 | 0.050 |
Why?
|
| Hungary | 1 | 2017 | 81 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 346 | 0.040 |
Why?
|
| Linear Models | 1 | 2008 | 6073 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2007 | 1894 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 1303 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2018 | 539 | 0.040 |
Why?
|
| Hernia, Ventral | 1 | 2018 | 136 | 0.040 |
Why?
|
| Wound Healing | 2 | 2017 | 2791 | 0.040 |
Why?
|
| Osteogenesis | 2 | 2002 | 1234 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2020 | 692 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 534 | 0.040 |
Why?
|
| Steroids | 1 | 2021 | 779 | 0.040 |
Why?
|
| Time | 1 | 2017 | 528 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6754 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 913 | 0.040 |
Why?
|
| Piperazines | 1 | 2007 | 2475 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 40276 | 0.040 |
Why?
|
| Cytokines | 2 | 2001 | 7006 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18133 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 1013 | 0.040 |
Why?
|
| Rats | 6 | 2002 | 25424 | 0.040 |
Why?
|
| Risk Management | 1 | 2019 | 569 | 0.040 |
Why?
|
| Colectomy | 1 | 2020 | 627 | 0.040 |
Why?
|
| Germany | 1 | 2017 | 819 | 0.040 |
Why?
|
| Neutrophils | 2 | 2018 | 3753 | 0.040 |
Why?
|
| Swine | 2 | 2014 | 5347 | 0.040 |
Why?
|
| Blotting, Northern | 3 | 2002 | 1683 | 0.040 |
Why?
|
| Antimalarials | 1 | 2021 | 803 | 0.040 |
Why?
|
| Head | 1 | 2020 | 753 | 0.040 |
Why?
|
| APACHE | 1 | 2015 | 275 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2953 | 0.040 |
Why?
|
| Animals | 10 | 2014 | 168501 | 0.040 |
Why?
|
| Abbreviated Injury Scale | 1 | 2014 | 35 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 391 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 3130 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 855 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 2647 | 0.040 |
Why?
|
| Starvation | 1 | 2014 | 147 | 0.030 |
Why?
|
| Vital Signs | 1 | 2015 | 115 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 11584 | 0.030 |
Why?
|
| Ethnic Groups | 1 | 2007 | 3351 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2002 | 20583 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10602 | 0.030 |
Why?
|
| Polymerization | 1 | 2014 | 166 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2015 | 242 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 446 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1667 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 20390 | 0.030 |
Why?
|
| Netherlands | 1 | 2017 | 2020 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3504 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 1411 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2015 | 504 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2001 | 13519 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 830 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 1846 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 826 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2328 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 561 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 983 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2007 | 7199 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1716 | 0.030 |
Why?
|
| Ileum | 1 | 2014 | 587 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 1059 | 0.030 |
Why?
|
| Pandemics | 2 | 2020 | 5107 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2017 | 886 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 4652 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 1573 | 0.030 |
Why?
|
| Liver | 2 | 2020 | 7475 | 0.030 |
Why?
|
| India | 1 | 2017 | 2129 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 2014 | 372 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2015 | 6310 | 0.030 |
Why?
|
| Prevalence | 2 | 2020 | 14259 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1404 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2626 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2013 | 974 | 0.030 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2010 | 23 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2002 | 297 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2018 | 4555 | 0.030 |
Why?
|
| Environment, Controlled | 1 | 2010 | 49 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2018 | 2828 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3601 | 0.030 |
Why?
|
| Health Services Research | 1 | 2018 | 1853 | 0.030 |
Why?
|
| Leukocytes | 1 | 2018 | 2091 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 631 | 0.020 |
Why?
|
| Mice | 3 | 2014 | 79108 | 0.020 |
Why?
|
| Anesthetics | 1 | 2014 | 487 | 0.020 |
Why?
|
| Registries | 2 | 2015 | 7622 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2002 | 8745 | 0.020 |
Why?
|
| Morbidity | 1 | 2014 | 1607 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2015 | 1160 | 0.020 |
Why?
|
| Cell Division | 3 | 2002 | 4942 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 1020 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1471 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1804 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2060 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3941 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2017 | 11917 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 407 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2425 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6691 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 18921 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21201 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2499 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2002 | 610 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2964 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3203 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 688 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2015 | 1094 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 3911 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 11578 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2020 | 2843 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3453 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2001 | 11593 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 8086 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 1540 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4407 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 1384 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4142 | 0.020 |
Why?
|
| Students, Medical | 1 | 2015 | 1496 | 0.020 |
Why?
|
| Pregnancy | 2 | 2019 | 24677 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2002 | 45 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2018 | 3628 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2002 | 188 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2001 | 512 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 173 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9927 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2002 | 281 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 2949 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2000 | 805 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 595 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 921 | 0.010 |
Why?
|
| Gene Expression | 2 | 2002 | 8071 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 12859 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 1149 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 6623 | 0.010 |
Why?
|
| Mandible | 1 | 2000 | 712 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2503 | 0.010 |
Why?
|
| Osteotomy | 1 | 2000 | 777 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5751 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 33054 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 5168 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 7024 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6463 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 32095 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 12057 | 0.000 |
Why?
|
| Aging | 1 | 2000 | 8050 | 0.000 |
Why?
|